04.12.2012 Views

Acute Aortic Disease.. - Index of

Acute Aortic Disease.. - Index of

Acute Aortic Disease.. - Index of

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Endovascular Thoracic <strong>Aortic</strong> Stent Grafting 289<br />

positioning, single lung ventilation for thoracotomy, or injuries precluding systemic<br />

heparinization.<br />

Due to the significant morbidity and mortality associated with surgical<br />

repair <strong>of</strong> traumatic aortic injury in this group <strong>of</strong> severely injured patients, there has<br />

been a growing interest in the emergent treatment <strong>of</strong> traumatic aortic transection<br />

with TEVAR (Fig. 10). The minimally invasive approach <strong>of</strong> TEVAR <strong>of</strong>fers these<br />

<strong>of</strong>ten severely injured patients a less morbid intervention.<br />

Reed and coworkers recently reviewed their experience with traumatic<br />

transections over a 5-year period from 2000–2005. A total <strong>of</strong> 51 patients presented<br />

with the diagnosis <strong>of</strong> traumatic transection. Twenty-seven (52%) patients died<br />

before intervention. Of the remaining 24 patients, nine patients underwent<br />

emergent conventional open repair. Thirteen patients underwent delayed TEVAR,<br />

with the mean duration from diagnosis to treatment <strong>of</strong> 6 days. Technical success<br />

with complete exclusion <strong>of</strong> the transection was achieved in all 13 patients. Thirtyday<br />

mortality was 23% (n = 3) (74).<br />

Multiple small series have demonstrated that TEVAR in the acute setting<br />

for traumatic transections can be performed with excellent technical success and<br />

acceptable perioperative morbidity and mortality, when compared to conventional<br />

open repair. Tehrani et al. (75) reported their experience <strong>of</strong> 30 patients with traumatic<br />

aortic and severe concomitant nonaortic injuries treated with TEVAR.<br />

Technical success was 100% with angiographic evidence <strong>of</strong> complete exclusion<br />

<strong>of</strong> the disruption. There were two peri-procedural deaths and no incidence <strong>of</strong> paraplegia.<br />

With a mean follow-up <strong>of</strong> 11.6 months, there was no evidence <strong>of</strong> endoleak,<br />

stent migration, or late pseudoaneurysm formation. Other smaller series have<br />

demonstrated similar findings, with a mean follow-up period up to 21 months<br />

(21,67,76,77,100). Peri-procedural mortality rates range from 0% to 11%, with no<br />

incidence <strong>of</strong> paraplegia. All endovascular stent graft deployment was performed<br />

Figure 10 Thoracic endovascular aortic repair <strong>of</strong> traumatic transection (white arrow).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!